UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported)
May 19, 2016
Dewmar International BMC, Inc.
(Exact Name of Registrant as Specified in Its Charter)
NEVADA
(State or Other Jurisdiction of Incorporation)
001-32032 | 26-4465583 |
(Commission File Number) | (IRS Employer Identification No.) |
132 E. Northside Dr., Suite C
Clinton, Mississippi 39065
(Address of Principal Executive Offices) (Zip Code)
(601) 488-4360
(Registrant's Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01 - OTHER EVENTS
Authorized Shares
As of May 19, 2016, the Company’s total number of Authorized Shares is 4,500,000,000 with the number of Issued and Outstanding shares currently at 2,426,163,513. The current float remains at 2,225,613,590 shares.
Liquidity
As of March 31, 2016 the Company’s cash and cash equivalents exceed $800,000.00
Classification or SIC Code
On December 10, 2014 Dewmar International BMC, Inc. (“the Company’) changed its primary Industry Classification or SIC code from 2080 Beverages to 8741 Management Services to more accurately reflect the Company’s broad portfolio of products and services it manages across various vertical markets.
Today, Dewmar International BMC, Inc. is a diversified operating company headquartered in Clinton, Mississippi. The Company conducts business across a variegated set of categories and sectors including consumer goods, wholesale trade, pharmaceuticals and health sciences.
The Company and its subsidiaries develop, market and distribute goods, therapeutics and services in national and international markets through licensing agreements, e-commerce platforms, fee-for-service arrangements and distribution contracts.
The Company’s business strategy is to identify paradigm shifts occurring in large, traditional or growth markets within the Company’s sphere of expertise to create innovative products, services and/or financial offerings that exploit new market opportunities.
Recent Filings of 1934 Act Periodic Reports
Dewmar has filed the following financial forms with the SEC since the third quarter of 2015:
August 11, 2015
Form 10K
Annual Report for the fiscal year ended December 31, 2013
September 25, 2015
Form 8K
Classification or SIC Code
Statement of Authorized Shares
Statement of Issued & Outstanding Shares
Statement of Float
November 5, 2015
Form 8K
Consolidated Balance Sheet 12-31-14
Consolidated Cash Flow Statement 12-31-14
Consolidated Profit & Loss Statement 12-31-14
May 5, 2016
Form 10Q
Quarterly Report for the fiscal quarter ended March 31, 2014
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 19, 2016
By: /s/ Marco Moran
Name: Marco Moran
Title: Chief Executive Officer
3
